Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Anemia × Estradiol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1 Classical hematology 1

Conditions

Breast Neoplasms 14 Polycystic Ovary Syndrome 12 Leiomyoma 6 Menorrhagia 5 Osteoporosis 2 Neoplasm Metastasis 2 Vaginitis 1 Triple Negative Breast Neoplasms 1 Sexual Dysfunction, Physiological 1 Prostatic Neoplasms 1 Pregnancy Complications 1 Postmenopausal Vaginal Atrophy 1 Neoplasms 1 Infertility, Female 1 Infertility 1 Hyperandrogenism 1 Hot Flashes 1 Estrogen Receptor Positive Breast Cancer 1 Estrogen Levels Among Breast Cancer Patients 1 Endometriosis 1 Coronary Disease 1 Cardiovascular Diseases 1 Breast Carcinoma In Situ 1 Atrophic Vaginitis 1 Anemia 1 Anatomic Stage III Breast Cancer AJCC v8 1 Abortion, Spontaneous 1

Interventions

Epoetin Alfa 51 Darbepoetin alfa 35 epoetin beta 14 ferric carboxymaltose 11 Cyclophosphamide 5 luspatercept 4 fludarabine phosphate 4 fludarabine 4 Erythropoietin 4 Cyclosporine 4 Cisplatin 4 Busulfan 4 Blood Transfusion 4 ACE-011 4 peginesatide 3 hematide 3 ferrous sulfate 3 ferric gluconate 3 Radiotherapy 3 Lenalidomide 3 Iron-Dextran Complex 3 Filgrastim 3 Erythrocyte Transfusion 3 Biopsy 3 Antilymphocyte Serum 3 thymoglobulin 2 ruxolitinib 2 iron isomaltoside 1000 2 ferrous fumarate 2 continuous erythropoietin receptor activator 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00303784 2020-11-27

PATCH

University College, London

Phase 3 Unknown

Classical hematologyGenitourinary

Anemia, Osteoporosis, Prostatic Neoplasms, Hot Flashes

Data powered by HemOnc (CC BY 4.0) Colophon ⚡